Key Takeaways
- • Confido Health raised a $12.5M series A extension, following its $10M series A announced in September, to scale an agentic AI operating layer that executes administrative workflows across medical practices, according to Fierce Healthcare.
- • Z47 (formerly Matrix Partners India) led the extension, with healthcare private equity veteran Justin Saks joining as investor and board advisor; Together Fund and Blume Ventures also participated.
- • Confido reports working with more than 1,500 sites of care, mostly independent practice groups, across 27 states, reaching about 3,200 providers, and says PE-backed provider groups are its key growth channel.
- • The company sells first to private equity sponsors and then expands into their portfolio companies, and reports 15x growth since its last round.
- • Confido claims over 95% AI handle rates, capacity equivalent to three to five full-time employees within three months of deployment, and projected provider savings of $10M to $15M annually.
Summary
Confido Health has secured a $12.5 million series A extension to scale its agentic AI platform, which the company says is expanding beyond AI voice agents into an operating system capable of executing administrative workflows across a medical practice, according to Fierce Healthcare. The extension follows a $10 million series A announced in September and was completed in February, according to the company. Z47, formerly Matrix Partners India, led the round. Healthcare private equity veteran Justin Saks joined as an investor and board advisor, and existing investors Together Fund and Blume Ventures also participated.
The platform integrates with more than 50 systems of record, including electronic health records, practice management, phone, billing and fax systems, without requiring practices to change their existing technology stack. Confido says its agents automate tasks such as appointment scheduling, insurance verification, billing and patient outreach. Co-founder and CEO Chetan Reddy described the goal as moving from systems of record to a "system of action" that adds capacity. Confido currently serves more than 1,500 sites of care in 27 states, reaching about 3,200 providers. The company reports that over 95% AI handle rates across key end-to-end office use cases, with capacity equivalent to three to five full-time employees on average within three months of deployment. Providers project $10 million to $15 million in annual savings, according to the company.
Confido's go-to-market strategy centers on private equity sponsors. The company sells to PE investors first and then expands into their portfolio companies, targeting multi-site provider groups facing staffing shortages, rising operating costs and fragmented technology. Executives say PE firms' AI teams evaluate vendors on technology, security, privacy and expected benefits before recommending solutions to portfolio companies. Reddy said the company has seen 15x growth since its last round. Michael Pascetta, chief financial officer of Vision Innovation Partners, said its practices doubled collections in the payments department after deploying Confido.
The raise comes amid rising PE ownership of physician practices. According to the American Medical Association's 2025 analysis, PE firms own approximately 6.5% of U.S. physician practices, with market share exceeding 30% and 50% in some local markets. Corporate entities including PE firms, insurers and pharmacy chains collectively own 30.1% of practices. Practices face double-digit operating cost increases, flat reimbursement and staffing shortages, with support staff compensation accounting for roughly 25% to 30% of practice revenue. Confido is targeting ophthalmology and optometry, physical therapy, dental, and primary and community care.
The company is part of a crowded field. EliseAI, Heidi, Suki, Assort Health and Artera have all raised substantial rounds to deploy AI agents across administrative and patient communication workflows, according to the report. Reddy, who said he spent 15 months visiting U.S. practices, framed the company's mission around staffing capacity and patient access.
The platform integrates with more than 50 systems of record, including electronic health records, practice management, phone, billing and fax systems, without requiring practices to change their existing technology stack. Confido says its agents automate tasks such as appointment scheduling, insurance verification, billing and patient outreach. Co-founder and CEO Chetan Reddy described the goal as moving from systems of record to a "system of action" that adds capacity. Confido currently serves more than 1,500 sites of care in 27 states, reaching about 3,200 providers. The company reports that over 95% AI handle rates across key end-to-end office use cases, with capacity equivalent to three to five full-time employees on average within three months of deployment. Providers project $10 million to $15 million in annual savings, according to the company.
Confido's go-to-market strategy centers on private equity sponsors. The company sells to PE investors first and then expands into their portfolio companies, targeting multi-site provider groups facing staffing shortages, rising operating costs and fragmented technology. Executives say PE firms' AI teams evaluate vendors on technology, security, privacy and expected benefits before recommending solutions to portfolio companies. Reddy said the company has seen 15x growth since its last round. Michael Pascetta, chief financial officer of Vision Innovation Partners, said its practices doubled collections in the payments department after deploying Confido.
The raise comes amid rising PE ownership of physician practices. According to the American Medical Association's 2025 analysis, PE firms own approximately 6.5% of U.S. physician practices, with market share exceeding 30% and 50% in some local markets. Corporate entities including PE firms, insurers and pharmacy chains collectively own 30.1% of practices. Practices face double-digit operating cost increases, flat reimbursement and staffing shortages, with support staff compensation accounting for roughly 25% to 30% of practice revenue. Confido is targeting ophthalmology and optometry, physical therapy, dental, and primary and community care.
The company is part of a crowded field. EliseAI, Heidi, Suki, Assort Health and Artera have all raised substantial rounds to deploy AI agents across administrative and patient communication workflows, according to the report. Reddy, who said he spent 15 months visiting U.S. practices, framed the company's mission around staffing capacity and patient access.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.